Status:
UNKNOWN
Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Overactive Bladder Syndrome
Eligibility:
FEMALE
20+ years
Phase:
PHASE4
Brief Summary
To investigate whether prolonged period of treatment (6 months) can have a better therapeutic outcome than conventional period (3 months) of antimuscarinics.
Detailed Description
Overactive bladder syndrome (OAB), with or without urge incontinence, is characterized by urinary urgency, frequency and nocturia. Thus, patients with OAB could be considered to have a reduced quality...
Eligibility Criteria
Inclusion
- Women who have overactive bladder syndrome
Exclusion
- Women who are less than 20 year-old
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01876186
Start Date
May 1 2013
End Date
December 1 2015
Last Update
July 7 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Obstetrics & Gynecology, National Taiwan University Hospital
Taipei, Taiwan, 100